A new study supports the market potential of fish oil yogurt.
One serving of yogurt may be an easy way for consumers to obtain their daily omega-3 nutrition requirements, according to a study published in the Journal of Dairy Science. Through a series of human taste tests, Virginia Tech researchers found potential for humans to consume-and enjoy-1% fish oil in a savory-flavored yogurt.
Thirty-one untrained tasters could not detect a difference between unflavored yogurt with butter oil and unflavored yogurt with low level (0.43%) of fish oil, but could detect oxidized fish oil, even at low usage levels. When trained tasters consumed savory-flavored yogurt (chili-lime) with high levels of fish oil-enough to provide the daily requirement recommended by the American Heart Association-fish flavor was considered more pronounced with 1% oxidized fish oil than 1% fresh fish oil.
Yogurt with the chili-lime flavor was acceptable to a significant portion of participants, suggesting that a savory flavor may help mask fish oil taste while providing a positive consumer experience. The researchers concluded that a potential market exists for this type of product.
The Journal of Dairy Science is the official journal of the American Dairy Science Association.
Recent animal study finds that Lysoveta may help reduce neonatal brain injury
July 17th 2024A recent animal study found that lysophosphatidylcholine (LPC)-bound omega-3 long-chain polyunsaturated fatty acids (LCPUFAs), marketed as Lysoveta by Aker BioMarine, protected against neonatal hypoxic-ischemic (HI) brain injury in mice.
Krill oil supplementation raises Omega-3 Index of Lupus patients in recent study
July 16th 2024The study was conducted at 20 research centers in the United States by Aker BioMarine and the Lupus Clinical Investigators Network with oversight by Lupus Therapeutics, the clinical research affiliate of the Lupus Research Alliance.
Meta-analysis does not find increased risk of bleeding events from omega-3 PUFA consumption
July 8th 2024Researchers reviewed 11 studies and found that there was no difference in the incidence of bleeding events between patients receiving omega-3 PUFAs and those not receiving them. High dose EPA consumption was associated with an elevated but modest risk.
Recent review states that pentadecanoic acid may support cellular stability for better longevity
June 25th 2024According to the paper’s author, Stephanie Venn-Watson, DVM, MPH, deficiency in pentadecanoic acid of ≤0.2% total circulating fatty acids increases the risk of ferroptosis, which a type of cell death cause by the peroxidation of fragile fatty acids in cell membranes that combines with iron thus increasing reactive oxygen species, and disabling mitochondria.